Preventing synaptic deficits in Alzheimer’s disease by inhibiting tumor necrosis factor alpha signaling
The characterization of preclinical stages of Alzheimer’s disease (AD) would provide a therapeutic window for prevention. One of the challenges of developing preventive therapy for AD is to identify early biomarkers for intervention studies. We have recently shown that in the TgCRND8 transgenic AD m...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-06-01
|
| Series: | IBRO Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2451830117300468 |